Seaport Therapeutics Balance Sheet
NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Seaport Therapeutics has no annual balance sheet on file yet, so quarterly figures are shown instead.
Seaport Therapeutics financial position
As of Jun 30, 2026, Seaport Therapeutics reported total assets of $441.7 million against total liabilities of $19.1 million. Shareholders' equity stood at $422.6 million, or 95.7% of assets. The company held $64.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 18.00, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Seaport Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 64.22M | 52.91M | — | — |
| Short-Term Investments | 209.09M | 129.70M | — | — |
| Total Current Assets | 282.18M | 188.34M | — | — |
| Property, Plant & Equipment | 360.00K | 386.00K | — | — |
| Long-Term Investments | 153.95M | 30.04M | — | — |
| Total Assets | 441.68M | 227.67M | — | — |
| Accounts Payable | 5.71M | 4.79M | — | — |
| Total Current Liabilities | 15.67M | 14.22M | — | — |
| Total Liabilities | 19.08M | 17.97M | — | — |
| Shareholders' Equity | 422.60M | -115.62M | -49.55M | -36.16M |
| Retained Earnings | -202.12M | -139.52M | — | — |
| Net Cash (Debt) | 273.31M | 182.60M | — | — |
| Shares Outstanding | 53.53M | 2.60M | — | — |
This table shows 4 quarterly periods of Seaport Therapeutics's balance sheet, from Q2 2026 back to Q? 2025, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow SPTX's reporting calendar. What is a balance sheet?